Meds & supplements › Tocilizumab
Medicine · Interleukin-6 Receptor Antagonist
Some people have died from these infections.
Selected manufacturer label information, organised into consistent sections by Sofidex. Read the full label at DailyMed ↗
WARNING: RISK OF SERIOUS INFECTIONS Patients treated with tocilizumab products including TOFIDENCE are at increased risk for developing serious infections that may lead to hospitalization or death. Most patients who developed these infections were taking concomitant immunosuppressants such as methotrexate or corticosteroids. If a serious infection develops, interrupt TOFIDENCE until the infection is controlled. Reported infections include: Active tuberculosis, which may present with pulmonary or extrapulmonary disease. Patients, except those with COVID-19, should be tested for latent tuberculosis before TOFIDENCE use and during therapy. Treatment for latent infection should be initiated prior to TOFIDENCE use. Invasive fungal infections, including candidiasis, aspergillosis, and pneumocystis. Patients with invasive fungal infections may present with disseminated, rather than localized, disease. Bacterial, viral and other infections due to opportunistic pathogens. The risks and benefits of treatment with TOFIDENCE should be carefully considered prior to initiating therapy in patients with chronic or recurrent infection. Patients should be closely monitored for the development of signs and symptoms of infection during and after treatment with TOFIDENCE, including the possible development of tuberculosis in patients who tested negative for latent tuberculosis infection prior to initiating therapy. WARNING: RISK OF SERIOUS INFECTIONS See full prescribing information for complete boxed warning. Serious infections leading to hospitalization or death including tuberculosis (TB), bacterial, invasive fungal, viral, and other opportunistic infections have occurred in patients receiving tocilizumab products. Perform test for latent TB (except patients with COVID-19); if positive, start treatment for TB prior to starting TOFIDENCE. Monitor all patients for active TB during treatment, even if initial latent TB test is negative.
TOFIDENCE can cause serious side effects including: Serious Infections. TOFIDENCE is a medicine that affects your immune system. TOFIDENCE can lower the ability of your immune system to fight infections. Some people have serious infections while taking TOFIDENCE, including tuberculosis (TB), and infections caused by bacteria, fungi, or viruses that can spread throughout the body.
Some people have died from these infections. Your healthcare provider should assess you for TB before starting TOFIDENCE (except if you have COVID-19). If you have COVID-19, your healthcare provider should monitor you for signs and symptoms of new infections during and after treatment with TOFIDENCE. Your healthcare provider should monitor you closely for signs and symptoms of TB during and after treatment with TOFIDENCE.
You should not start taking TOFIDENCE if you have any kind of infection unless your healthcare provider says it is okay. Before starting TOFIDENCE, tell your healthcare provider if you: think you have an infection or have symptoms of an infection, with or without a fever, such as: sweating or chills shortness of breath warm, red, or painful skin or sores on your body feel very tired muscle aches blood in phlegm diarrhea or stomach pain cough weight loss burning when you urinate or urinating more often than normal are being treated for an infection.
get a lot of infections or have infections that keep coming back. have diabetes, HIV, or a weak immune system. People with these conditions have a higher chance for infections. have TB, or have been in close contact with someone with TB. live or have lived, or have traveled to certain parts of the country (such as the Ohio and Mississippi River valleys and the Southwest) where there is an increased chance for getting certain kinds of fungal infections (histoplasmosis, coccidiomycosis, or blastomycosis).
These infections may happen or become more severe if you use TOFIDENCE. Ask your healthcare provider, if you do not know if you have lived in an area where these infections are common. have or have had hepatitis B. After starting TOFIDENCE, call your healthcare provider right away if you have any symptoms of an infection.
TOFIDENCE can make you more likely to get infections or make worse any infection that you have. Tears (perforation) of the stomach or intestines. Tell your healthcare provider if you have had diverticulitis (inflammation in parts of the large intestine) or ulcers in your stomach or intestines. Some people taking TOFIDENCE get tears in their stomach or intestine.
This happens most often in people who also take nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, or methotrexate. Tell your healthcare provider right away if you have fever and new onset stomach-area pain that does not go away, and a change in your bowel habits. Liver problems (Hepatotoxicity): Some people have experienced serious life-threatening liver problems, which required a liver transplant or led to death.
Your healthcare provider may tell you to stop taking TOFIDENCE if you develop new or worse liver problems during treatment with TOFIDENCE. Tell your healthcare provider right away if you have any of the following symptoms: feeling tired (fatigue) lack of appetite for several days or longer (anorexia) yellowing of your skin or the whites of your eyes (jaundice) abdominal swelling and pain on the right side of your stomach-area light colored stools weakness nausea and vomiting confusion dark "tea-colored" urine Changes in certain laboratory test results.
Your healthcare provider should do blood tests before you start receiving TOFIDENCE. If you have rheumatoid arthritis (RA) or giant cell arteritis (GCA) your healthcare provider should do blood tests every 4 to 8 weeks after you start receiving TOFIDENCE for the first 6 months and then every 3 months after that. If you have polyarticular juvenile idiopathic arthritis (PJIA) you will have blood tests done every 4 to 8 weeks during treatment.
If
" for more information about side effects. What is TOFIDENCE? TOFIDENCE is a prescription medicine called an Interleukin-6 (IL-6) receptor antagonist. TOFIDENCE is used: To treat adults with moderately to severely active rheumatoid arthritis (RA), after at least one other medicine called a Disease-Modifying Anti-Rheumatic Drug (DMARD) has been used and did not work well.
To treat adults with giant cell arteritis (GCA). To treat people with active PJIA ages 2 and above. To treat people with active SJIA ages 2 and above. To treat hospitalized adults with coronavirus disease 2019 (COVID-19) receiving systemic corticosteroids and requiring supplemental oxygen or mechanical ventilation. It is not known if TOFIDENCE is safe and effective in children with PJIA or SJIA under 2 years of age or in children with conditions other than PJIA or SJIA.
Do not take TOFIDENCE: if you are allergic to tocilizumab products, or any of the ingredients in TOFIDENCE. See the end of this Medication Guide for a complete list of ingredients in TOFIDENCE. Before you receive TOFIDENCE, tell your healthcare provider about all of your medical conditions, including if you: have an infection.
have liver problems. have any stomach-area (abdominal) pain or been diagnosed with diverticulitis or ulcers in your stomach or intestines. have had a reaction to tocilizumab products or any of the ingredients in TOFIDENCE before. have or had a condition that affects your nervous system, such as multiple sclerosis. have recently received or are scheduled to receive a vaccine: All vaccines should be brought up-to-date before starting TOFIDENCE, unless urgent treatment initiation is required.
People who take TOFIDENCE should not receive live vaccines. People taking TOFIDENCE can receive non-live vaccines. plan to have surgery or a medical procedure. are pregnant or plan to become pregnant. TOFIDENCE may harm your unborn baby. Tell your healthcare provider if you become pregnant or think you may be pregnant during treatment with TOFIDENCE.
are breastfeeding or plan to breastfeed. It is not known if TOFIDENCE passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby if you take TOFIDENCE. Tell your healthcare provider about all of the medicines you take, including prescription, over-the-counter medicines, vitamins and herbal supplements.
TOFIDENCE and other medicines may affect each other causing side effects. Especially tell your healthcare provider if you take: any other medicines to treat your RA. Taking TOFIDENCE with these medicines may increase your risk of infection. medicines that affect the way certain liver enzymes work. Ask your healthcare provider if you are not sure if your medicine is one of these.
Know the medicines you take. Keep a list of them to show to your healthcare provider and pharmacist when you get a new medicine. How will I receive TOFIDENCE? Into a vein (IV or intravenous infusion) for Rheumatoid Arthritis, Giant Cell Arteritis, PJIA, SJIA, or COVID-19: If your healthcare provider prescribes TOFIDENCE as an IV infusion, you will receive TOFIDENCE from a healthcare provider through a needle placed in a vein in your arm.
The infusion will take about 1 hour to give you the full dose of medicine. For rheumatoid arthritis, giant cell arteritis or PJIA you will receive a dose of TOFIDENCE about every 4 weeks. For SJIA you will receive a dose of TOFIDENCE about every 2 weeks. For COVID-19, you will receive a single dose of TOFIDENCE, and if needed one additional dose.
While taking TOFIDENCE, you may continue to use other medicines that help treat your rheumatoid arthritis, PJIA, SJIA, or COVID-19 such as methotrexate, non-steroidal anti-inflammatory drugs (NSAIDs) and prescription steroids, as instructed by your healthcare provider. Keep all of your follow-up appointments and get your blood tests as ordered by your healthcare provider.
What are the possible side effects with TOFIDENCE? TOFIDENCE can cause serious side effects, including: Hepatitis B infection in people who carry the virus in their blood. If you are a carrier of the hepatitis B virus (a virus that affects the liver), the virus may become active while you use TOFIDENCE. Your healthcare provider may do blood tests before you start treatment with TOFIDENCE and while you are using TOFIDENCE.
Tell your healthcare provider if you have any of the following symptoms of a possible hepatitis B infection: feel very tired vomiting chills dark urine skin or eyes look yellow clay-colored bowel movements stomach discomfort skin rash little or no appetite fevers muscle aches Serious Allergic Reactions. Serious allergic reactions, including death
sofidex [Internet]. Daloreum; c2026. Tocilizumab; [reviewed 2026 Aug 2; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/tocilizumab
sofidex. (2026, August 2). Tocilizumab. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/tocilizumab
Tocilizumab. sofidex. Reviewed August 2, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/tocilizumab
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.